Technology News and Research

RSS

Challenges faced in cardiac imaging

When patients present with chest pain or other high-risk symptoms of heart problems, doctors increasingly rely on nuclear imaging and computed tomography (CT) tests to find out whether there is evidence of heart disease, blockages in the coronary arteries or reduced blood flow to the heart. Results of these procedures can help guide life-saving prevention and treatment options.

11 May 2010

SNP biomarker could reduce guesswork associated with prescribing drugs

A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.

11 May 2010

UCF receives $1.9M NIH grant for exploring new ways of reversing damage caused by MS

A National Institutes of Health grant will help University of Central Florida researchers explore new ways to potentially reverse the damage caused by multiple sclerosis and other neurological disorders.

11 May 2010

Research may aid in developing new cancer therapies

Immortality and uncontrolled cell division are the fundamental differences between cancer cells and normal cells.

11 May 2010

Vigorous physical activity in childhood strengthens hip bones

Researchers from Southhampton and Cambridge Universities in the UK have presented evidence that vigorous physical activity in young children results in stronger hip bones. The results were presented at the World Congress on Osteoporosis (IOF WCO-ECCEO10) in Florence, Italy.

11 May 2010

ACADIA Pharmaceuticals reports increased revenue in first-quarter 2010

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the first quarter ended March 31, 2010.

11 May 2010

BIOTRONIK launches TactiCath irrigated RF contact force ablation catheter for treating AF

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of remote monitoring technologies today announced the market release of the TactiCath catheter. The TactiCath catheter, an Endosense company product, is an irrigated RF contact force ablation catheter with features that offer a major advance in ablation therapy for patients with cardiac arrhythmias and particularly Atrial Fibrillation (AF).

11 May 2010

Iris Biotechnologies receives two new Canadian patents

Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents.

11 May 2010

Alexza Pharmaceuticals first-quarter net loss increases to $13.4 million

Alexza Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010 and provided a business update.

11 May 2010

PositiveID reports $673,000 revenue for first-quarter 2010

PositiveID Corporation announced that it has reported financial results for the quarter ended March 31, 2010, its first full quarter of operations since its acquisition of Steel Vault Corporation in November 2009 and the resulting name change to PositiveID. The Company reported revenues of $673,000 for the first quarter of 2010, compared to revenues of $8,000 for the first quarter of 2009.

10 May 2010

CHRISTUS Health selects Wolters Kluwer Health's ProVation Order Sets electronic solution

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that CHRISTUS Health has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as its electronic order set solution. In addition to automating development and maintenance, ProVation Order Sets will provide clinicians at 24 CHRISTUS facilities with point-of-care access to order sets and other intuitive clinical decision support tools.

10 May 2010

Study results of CTT's Calmare Pain Therapy for CIPN to be presented

Competitive Technologies, Inc. announced today that Thomas J. Smith, M.D., Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit Virginia Commonwealth University's Massey Cancer Center, will present results of his study evaluating the treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTT's Calmare® Pain Therapy Treatment.

10 May 2010

Companies await health IT windfall

The Washington Post: A Virginia firm, Vangent, is positioning "itself for a surge of federal spending on health information technology" by setting up a health IT strategy group. "Vangent is likely to face stiff competition for those dollars, but company officials say they expect the firm's reputation as a health-related services provider to serve it well as it bids on contracts." The firm is also involved in civil, defense and national security work, but health services are its largest business.

10 May 2010

Enzon reports income from continuing operations of $20.8M for first-quarter 2010

Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.

10 May 2010

Endosense commences enrollment in EFFICAS I study with TactiCath force-sensing catheter

Endosense, a Swiss medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced it has enrolled the first patients in EFFICAS I, the first study of the EFFICAS series. These patients were enrolled in Na Homolce Hospital, Prague, Czech Republic and treated by Petr Neuzil, M.D. and Vivek Reddy, M.D.

10 May 2010

Bovie Medical first-quarter revenues decrease to $5.6M

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2010.

10 May 2010

St. Jude Medical introduces Wireless USB Adaptor for Merlin@home transmitter in the U.S.

St. Jude Medical, Inc., a global medical device company, today announced the U.S. launch of its Wireless USB Adaptor for the Merlin@home™ transmitter, a system that allows important patient data from an implantable cardiac device to be wirelessly downloaded and securely transmitted via telephone for review by a physician. The new Wireless USB Adaptor enables patients using a Merlin@home transmitter to transmit data to their physician over cellular networks, allowing for more convenient care than existing landline services provide.

10 May 2010

Technology News and Research

Challenges faced in cardiac imaging

SNP biomarker could reduce guesswork associated with prescribing drugs

UCF receives $1.9M NIH grant for exploring new ways of reversing damage caused by MS

Research may aid in developing new cancer therapies

Vigorous physical activity in childhood strengthens hip bones

ACADIA Pharmaceuticals reports increased revenue in first-quarter 2010

BIOTRONIK launches TactiCath irrigated RF contact force ablation catheter for treating AF

Iris Biotechnologies receives two new Canadian patents

Alexza Pharmaceuticals first-quarter net loss increases to $13.4 million

PositiveID reports $673,000 revenue for first-quarter 2010

CHRISTUS Health selects Wolters Kluwer Health's ProVation Order Sets electronic solution

Study results of CTT's Calmare Pain Therapy for CIPN to be presented

Companies await health IT windfall

Enzon reports income from continuing operations of $20.8M for first-quarter 2010

Endosense commences enrollment in EFFICAS I study with TactiCath force-sensing catheter

Bovie Medical first-quarter revenues decrease to $5.6M

St. Jude Medical introduces Wireless USB Adaptor for Merlin@home transmitter in the U.S.

Shamir first-quarter revenue up 18.2% to $40.1 million

First Edition: May 10, 2010

Osteotech reports overall sequential revenue growth of 117% for first-quarter 2010

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News